For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
日本語
Menu
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
日本語
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
日本語
Menu
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
日本語
Twitter
Facebook-f
Latest in Regenerative Medicine
All
Cancer
Heart Disease
Ophthalmic / Neurological Disorders
Other
Kyoto University has generated iPS cells with less risk of rejection by genome editing
•
March 1, 2021
•
Cancer
Kyoto University has succeeded in regenerating T-cells from human iPS cells that enhance effects of cancer immunotherapy(2018)
•
February 22, 2021
•
Cancer
Kyoto University developed a scalable method to regenerate T-cells from iPSCs
•
February 3, 2021
•
Cancer
Alzheimer’s patient iPS-derived neurons lead to the discovery of genetic mechanisms underlying the cause of disease.
•
December 4, 2020
•
Ophthalmic / Neurological Disorders
Novel approach to an iPS cell-based therapy for cervical cancer
•
November 14, 2020
•
Cancer
Stanford researchers use iPSCs to model heart disease in a dish and discover potential drug for treatment
•
October 2, 2020
•
Heart Disease
Clinical trial of iPSC-derived MSCs for treatment of steroid-resistant Graft-versus-host disease
•
September 25, 2020
•
Other
Reach out to us to learn more
Contact Us